Pharma Japan
Subscription Required: Yes
Pharma Japan provides up-to-date news, insights, and analysis on the Japanese pharmaceutical industry, including regulatory changes, market trends, and company developments. LATEST NEWS
- Celltrion’s Eylea Biosimilar Nears Approval, but Listing Outlook Clouded
- Japan Panel to Review Joenja, Dojolvi for Approval at March 5 Session
- GSK Files Hep B Drug in Japan as First Global Submission
- Executives Urge Stronger CDMO, CRO Base at Drug Discovery WG Meeting
- Astellas Doubles Labor Productivity Since FY2020, Credits Organization Rejig
- Sumitomo Regains DSP-0187 Rights as Jazz Calls Off Deal
- Japan to Closely Monitor US “MFN” Policy: PM Takaichi